Article
Predicting Tumor Mutational Burden from UHF-Dielectrophoresis Crossover Frequency
2024-11-06
Abstract excerpt
<h4>ABSTRACT</h4> Tumor Mutational Burden (TMB) has emerged as a crucial biomarker to guide patient eligibility for immunotherapy. However, whole exome sequencing, the gold-standard method for TMB measurement, remains limited in accessibility due to its high costs, operational complexity, and lengthy processing times. To address these limitations, we investigated whether Ultra-High-Frequency (UHF) technology coul...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8df5de51-ed93-5c87-b985-88977ab9c669
- DOI
- 10.1101/2024.11.05.622085
